Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis

IntroductionProstate cancer (PC), the most common male genitourinary malignancy and second leading cause of global cancer deaths in men, frequently progresses to lethal castration-resistant PC (CRPC). Ginsenoside Rh2 (GRh2), a ginseng-derived bioactive compound, exhibits antitumor potential, but its...

全面介紹

書目詳細資料
發表在:Frontiers in Oncology
Main Authors: Zhen He, Jianxi Shi, Bing Zhu, Zhentao Tian, Zhihong Zhang, Changwen Zhang
格式: Article
語言:英语
出版: Frontiers Media S.A. 2025-08-01
主題:
在線閱讀:https://www.frontiersin.org/articles/10.3389/fonc.2025.1633891/full